Download PDF
Thromb Haemost 1972; 28(01): 031-048
DOI: 10.1055/s-0038-1649039
Original Article
Schattauer GmbH

The Effects of Brinolase (Fibrinolytic Enzyme from Aspergillus Oryzae) on Platelet Aggregation of Dog and Man

W. H. E Roschlau
1   Department of Pharmacology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
,
R Gage
1   Department of Pharmacology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
29 June 2018 (online)

    Permissions and Reprints

Summary

Inhibition of blood platelet aggregation by brinolase (fibrinolytic enzyme from Aspergillus oryzae) has been demonstrated with human platelets in vitro and with dog platelets in vivo and in vitro, using both ADP and collagen as aggregating stimuli. It is suggested that the optimal inhibitory effects of brinolase occur indirectly through the generation of plasma fibrinogen degradation products, without compromising platelet viability, rather than by direct proteolysis of platelet structures.

 

  • References

  • 1 Ardlie N. G, Glew G, and Schwartz C. J. 1966; Influence of catecholamines on nucleotideinduced platelet aggregation. Nature 212: 415.
    CrossrefPubMedGoogle Scholar
  • 2 Bergkvist R. 1963; a The proteolytic enzymes of Aspergillus oryzae. I. Methods for the estimation and isolation of the proteolytic enzymes. Acta chemica Scandinavica 17: 1521.
    CrossrefPubMedGoogle Scholar
  • 3 Bergkvist R. 1963; b The proteolytic enzymes of Aspergillus oryzae. II.Properties of the proteolytic enzymes. Acta chemica Scandinavica 17: 1541.
    CrossrefPubMedGoogle Scholar
  • 4 Bergkvist R. 1963; c The proteolytic enzymes of Aspergillus oryzae. III. A comparison of the fibrinolytic and fibrinogeno lytic effects of the enzymes. Acta chemica Scandinavica 17: 2230.
    CrossrefPubMedGoogle Scholar
  • 5 Bergkvist R. 1963; d The proteolytic enzymes of Aspergillus oryzae. IV. On the inhibition of the enzymes by serum. Acta chemica Scandinavica 17: 2239.
    CrossrefPubMedGoogle Scholar
  • 6 Bergkvist R, and Svärd P. O. 1964; Studies on the thrombolytic activity of a protease from Aspergillus oryzae. Acta physiologica Scandinavica 60: 363.
    CrossrefPubMedGoogle Scholar
  • 7 Born G. V. R. 1962; Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927.
    PubMedGoogle Scholar
  • 8 Bygdeman S. 1967; Effect of an Aspergillus enzyme on adenosine-diphosphate (ADP) induced platelet aggregation and adhesiveness. Life Science 6: 499.
    CrossrefPubMedGoogle Scholar
  • 9 DeGaetano G, Vermylen J, and Verstraete M. 1971; L’ inhibition de l’agrégation plaquet-taire: Données expérimentales et perspectives cliniques. Nouvelle Revue Française d’Hématologie 11: 339.
    PubMedGoogle Scholar
  • 10 DeNicola P, Gibelli A, Turazza G, and Giarola P. 1967; Influence of an Aspergillus enzyme on ADP-induced platelet aggregation and fibrinolysis. Life Science 6: 1233.
    CrossrefPubMedGoogle Scholar
  • 11 Dyer A. E, and Kadar D. 1964; Fibrin suspension assay for fibrinolytic activity. Blood 23: 729.
    PubMedGoogle Scholar
  • 12 Egan E. L. 1969; Local use of protease in haemodialysis clotting problems. Journal of the Irish Medical Association 62: 179.
    PubMedGoogle Scholar
  • 13 Freedman H. J, and Roschlau W. H. E. 1970; Some factors influencing the toxicity of thrombolytic enzymes (Brinase). Canadian Journal of Physiology and Pharmacology 48: 69.
    CrossrefPubMedGoogle Scholar
  • 14 French J. E. 1966; Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to the endothelium. International Review of Experimental Pathology 5: 253.
    PubMedGoogle Scholar
  • 15 Frisch P, Hedin L, Lund F, and Magnusson G. 1970. Intraarterielle regionale Thrombolyse mit Protease I. Tierexperimentelle Untersuchung über eine mögliche Interferenz mit Röntgenkontrastmittel. In: Marx R, and Thies H. A. (eds.) Thrombose und Embolie. F. K. Schattauer Verlag; Stuttgart-New York.: 231.
    Google Scholar
  • 16 Giering J. E, and Truant A. P. 1966; An experimental method for quantitative evaluation of thrombolysis : Effect of CA-7, a protease from Aspergillus oryzae. Angiology 17: 661.
    CrossrefPubMedGoogle Scholar
  • 17 Haslam R. J. 1964; Role of adenosine diphosphate in the aggregation of human blood platelets by thrombin and by fatty acids. Nature 202: 765.
    CrossrefPubMedGoogle Scholar
  • 18 Horace J. F, and Stefanini M. 1959; Fibrinolysis III. Nutritional and environmental requirements for optimum production of fibrinolysin from Aspergillus (Aspergillin 0). Proceedings of the Society for Experimental Biology and Medicine 102: 201
    PubMedGoogle Scholar
  • 19 Hovig T. 1963; Release of platelet-aggregating substance (adenosine diphosphate) from rabbit blood platelets induced by saline “extract” of tendons. Thrombosis et Diathesis Haemorrhagica 9: 264.
    PubMedGoogle Scholar
  • 20 Huang C. L, O’Brien E. T, and Thornes R. D. 1969; The thrombolytic action of Protease I on experimentally produced venous thrombi in the dog. Irish Journal of Medical Science 2: 379.
    PubMedGoogle Scholar
  • 21 Ives D. A. J, and Tosoni A. L. 1967; Purification of CA-7, a thrombolytic fungal protease. Canadian Journal of Biochemistry 45: 1055.
    CrossrefPubMedGoogle Scholar
  • 22 Jürgens J. 1966 a Experience with the therapeutic use of Protease I and CA 7 in about 50 patients. Personal communication.
    PubMedGoogle Scholar
  • 23 Jürgens J. 1966; b Effect of an Aspergillus enzyme on platelet aggregation in humans. Life Science 5: 1379.
    CrossrefPubMedGoogle Scholar
  • 24 Jürgens J, Lindvall S, Magnusson O, and Orth K. 1970; Proteolytic inhibitors in plasma from man treated with a protease from Aspergillus oryzae. Acta physiologica Scandinavica 78: 11.
    CrossrefPubMedGoogle Scholar
  • 25 Kessel M, Bennhold I, and Froese P. 1968; Untersuchungen über die Wirksamkeit eines neuen fibrinolytischen Enzyms zur lokalen Thrombolyse am Scribner-Shunt. Klinische Wochenschrift 46: 1263.
    CrossrefPubMedGoogle Scholar
  • 26 Kiessling H, and Svenson R. 1970; Influence of an enzyme from Aspergillus oryzae, Protease I, on some components of the fibrinolytic system. Acta chemica Scandinavica 24: 569.
    CrossrefPubMedGoogle Scholar
  • 27 Kopeć M, Budzyński A, Stachurska J, Wegrzynowicz Z, and Kowalski E. 1966; Studies on the mechanism of interference by fibrinogen degradation products (FDP) with platelet function. Role of fibrinogen in the platelet atmosphere. Thrombosis et Diathesis Haemorrhagica 15: 476.
    PubMedGoogle Scholar
  • 28 Kowalski E, Kopeć M, and Wegrzynowicz Z. 1963; Influence of fibrinogen degradation products (FDP) on platelet aggregation, adhesiveness and viscous metamorphosis. Thrombosis et Diathesis Haemorrhagica 10: 406.
    PubMedGoogle Scholar
  • 29 Larrieu M. J. 1971. Action of fibrinogen degradation products and fibrin monomer soluble complexes on platelet aggregation. In: Verstraete M, Vermyleist J, and Donati M. B. (eds.) Fibrinogen Degradation Products. Munksgaard; Copenhagen: 273.
    Google Scholar
  • 30 Latallo Z. S, Teisseyre E, Wegrzynowicz Z, and Kopeć M. 1971. Degradation of fibrinogen by proteolytic enzymes. In: Verstraete M, Vermylen J, and Donati M. B. (eds.) Fibrinogen Degradation Products. Munksgaard; Copenhagen: 15.
    Google Scholar
  • 31 Lindvall S, Magnusson O, and Orth K. 1969; On the inhibition of a fibrinolytic enzyme from Aspergillus oryzae by serum. Acta chemica Scandinavica 23: 2165.
    CrossrefPubMedGoogle Scholar
  • 32 Lund F, Hellström L, and Frisch P. 1968; a Combined arteriography and regional thrombolytic therapy. Opuscula medica 13: 281.
    PubMedGoogle Scholar
  • 33 Lund F, Hellström L, and Frisch P. 1968; b Side effects observed in combined arteriography and regional thrombolytic therapy with protease. Opuscula medica 13: 396.
    PubMedGoogle Scholar
  • 34 Monkhouse F. C, Daramola F, and Gillespie R. J. 1964; The action of a proteolytic enzyme from Aspergillus oryzae on components of the blood clotting system. Canadian Journal of Physiology and Pharmacology 42: 377.
    CrossrefPubMedGoogle Scholar
  • 35 Mustard J. F. 1968; Hemostasis and thrombosis. Seminars in Hematology 5: 91.
    PubMedGoogle Scholar
  • 36 Mustard J. F, and Packham M. A. 1970; Thromboembolism – A manifestation of the response of blood to injury. Circulation 42: 1.
    CrossrefPubMedGoogle Scholar
  • 37 O’Brien E. T, Thornes R. D, O’Brien D, and Hogan B. 1968; Inhibition of antiplasmin, and fibrinolytic effect of protease in patients with cancer. Lancet 1: 136.
    PubMedGoogle Scholar
  • 38 O’Brien J. R. 1964; Variability in the aggregation of human platelets by adrenaline. Nature 202: 1188.
    CrossrefPubMedGoogle Scholar
  • 39 Parker J. M, and Boyd J. G. 1968; Safety of CA-7 (fibrinolytic enzyme) for direct pulmonary artery perfusion. International Journal of Clinical Pharmacology I: 545.
    PubMedGoogle Scholar
  • 40 Parker R. C. 1961. Methods of Tissue Culture. 3rd edn.. P. B. Hoeber, Inc.; New York: 53-61.
    Google Scholar
  • 41 Perry A. W. 1968; Treatment of clotting in arterial hemodialysis cannulae with CA-7 (fibrinolytic enzyme derived from Aspergillus oryzae). Canadian Medical Association Journal 98: 762.
    PubMedGoogle Scholar
  • 42 Roschlau W. H. E. 1964; The evaluation in the dog of a proteolytic enzyme derived from Aspergillus oryzae. Canadian Journal of Physiology and Pharmacology 42: 109.
    CrossrefPubMedGoogle Scholar
  • 43 Roschlau W. H. E. 1965; Natural protease resistance to CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Canadian Journal of Physiology and Pharmacology 43: 741.
    CrossrefPubMedGoogle Scholar
  • 44 Roschlau W. H. E. 1966; Systemic toxicity of CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Angiology 17: 882.
    CrossrefPubMedGoogle Scholar
  • 45 Roschlau W. H. E. 1968; Thrombolytic therapy with CA-7, a fibrinolytic enzyme from Aspergillus oryzae: A report of two representative cases. Canadian Medical Association Journal 98: 757.
    PubMedGoogle Scholar
  • 46 Roschlau W. H. E. 1971. a Brinase (CA-7). A new fibrinolytic agent. In: Losito R, and Longpre B. (eds.) Current Concepts of Coagulation and Hemostasis. F. K. Schattauer Verlag; Stuttgart-New York.: 229.
    Google Scholar
  • 47 Roschlau W. H. E. 1971. b The use of brinase (fibrinolytic enzyme from Aspergillus oryzae) in the management of clotting problems in long-term hemodialysis. In Mammen E. F, Anderson G. F, and Barnhart M. I. (eds.) Thrombolytic Therapy. F. K. Schattauer Verlag; Stuttgart-New York: 217.
    Google Scholar
  • 48 Roschlau W. H. E, and Fisher A. M. 1966; Thrombolytic therapy with local perfusions of CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Angiology 17: 670.
    CrossrefPubMedGoogle Scholar
  • 49 Roschlau W. H. E, Feeedman H. J, and Miller S. L. 1969; Pharmacological modification of the vascular response to systemically administered thrombolytic enzymes (CA-7). Canadian Journal of Physiology and Pharmacology 47: 369.
    CrossrefPubMedGoogle Scholar
  • 50 Roschlau W. H. E, and Tosoni A. L. 1965; Thrombolytic therapy with CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Canadian Journal of Physiology and Pharmacology 43: 731.
    CrossrefPubMedGoogle Scholar
  • 51 Schmidt H. W. 1965; Thrombolyse durch Plasminogen-Aktivierung und durch direkte Proteolyse. Arzneimittel-Forschung (Drug Research) 15: 132.
    PubMedGoogle Scholar
  • 52 Schmidt H. W. 1966; a Zur Thrombolyse mit verschiedenen Fibrinolytica. I. Untersuchungen an experimentellen menschlichen Nativblutthromben. Klinische Wochenschrift 44: 618.
    CrossrefPubMedGoogle Scholar
  • 53 Schmidt H. W. 1966; b Zur Thrombolyse mit verschiedenen Fibrinolytika. II. In vitro-Unter-suchungen an intravital entstandenen menschlichen Thromben. Klinische Wochenschrift 44: 621.
    CrossrefPubMedGoogle Scholar
  • 54 Spaet T. H, and Erichson R. B. 1966; The vascular wall in the pathogenesis of thrombosis. Thrombosis et Diathesis Haemorrhagica, Suppl 21: 67.
    PubMedGoogle Scholar
  • 55 Spaet T. H, and Zucker M. B. 1964; Mechanism of platelet plug formation and role of adenosine diphosphate. American Journal of Physiology 206: 1267.
    PubMedGoogle Scholar
  • 56 Stefanini M, Ad Amis D. M, Soardi F, Marin H. M, and Mele R. H. 1959; Purification of Aspergillin O. Lancet 2: 443.
    PubMedGoogle Scholar
  • 57 Stefanini M, and Marin H. M. 1958; Fibrinolysis. I. Fibrinolytic activity of extracts from nonpathogenic fungi. Proceedings of the Society for Experimental Biology and Medicine 99: 504.
    PubMedGoogle Scholar
  • 58 Svärd P. O. 1966; The effect of an enzyme preparation from Aspergillus oryzae on the aggregation of rabbit platelets in vitro. Scandinavian Journal of Haematology 3: 277.
    PubMedGoogle Scholar
  • 59 Thornes R. D. 1968; Inhibition of antiplasmin, and effect of Protease I in patients with leukaemia. Lancet 2: 1220.
    PubMedGoogle Scholar
  • 60 Tosoni A. L, Glass D. G, Ives D. A. J, Roschlau W. H. E, and Fisher A. M. 1970 Brinase — a blood-clot-lysing enzyme. Joint Conference of the American Chemical Society and the Chemical Institute of Canada, Toronto, Ontario, Canada, 27 May 1970.
    PubMedGoogle Scholar
  • 61 Wallen P. 1971. Plasmic degradation of fibrinogen. In: Verstraete M, Vermylen J, and Donati M. B. (eds.) Fibrinogen Degradation Products. Munksgaard; Copenhagen: 3.
    Google Scholar